Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands
- Resource Type
- Article
- Source
- In
JTO Clinical and Research Reports September 2023 4(9) - Subject
- Language
- ISSN
- 2666-3643